Prostate Cancer - Results from #25740

How we manage prostate biopsy and prostate cancer therapy in men with haemophilia - Abstract June 5, 2012

The role of abiraterone in the management of metastatic castration-resistant prostate cancer - Abstract June 5, 2012

Progress in the treatment of bone metastases in cancer patients - Abstract June 5, 2012

Diffusion-weighted MRI of adult male pelvic cancers - Abstract June 5, 2012

Pelvic lymph node dissection for prostate cancer: Frequency and distribution of nodal metastases in a contemporary radical prostatectomy series - Abstract June 5, 2012

Accuracy of primary systematic template guided transperineal biopsy of the prostate for locating prostate cancer: A comparison with radical prostatectomy specimens - Abstract June 5, 2012

Contemporary open and robotic radical prostatectomy practice patterns among urologists in the United States - Abstract June 5, 2012

Focal therapy for localised unifocal and multifocal prostate cancer: A prospective development study - Abstract June 5, 2012

Relief of urinary symptoms underappreciated benefit of early stage prostate cancer treatment June 5, 2012

Natural orifice translumenal endoscopic radical prostatectomy (NOTES RP): The evolution of the technique - Abstract June 5, 2012

Bone-modifying agents in the treatment of bone metastases in patients with advanced genitourinary malignancies: A focus on zoledronic acid - Abstract June 5, 2012

HDR brachytherapy combined with external beam radiation for localised prostate cancer: Early experience from the Sydney Cancer Centre - Abstract June 5, 2012

Prostate cancer foci detected on multiparametric magnetic resonance imaging are histologically distinct from those not detected - Abstract June 4, 2012

Bias due to missing SEER data in D'Amico risk stratification of prostate cancer - Abstract June 4, 2012

The impact of real-time elastography guiding a systematic prostate biopsy to improve cancer detection rate: A prospective study of 353 patients - Abstract June 4, 2012

Posttreatment prostate specific antigen nadir predicts prostate cancer specific and all cause mortality - Abstract June 4, 2012

Core length in prostate biopsy: Size matters - Abstract June 4, 2012

Are repeat prostate biopsies safe? A cohort analysis from the SEARCH database - Abstract June 4, 2012

Prostate specific antigen levels and prostate cancer detection rates in patients with end stage renal disease - Abstract June 4, 2012

Intermittent hormone therapy for prostate cancer inferior to continuous therapy June 3, 2012

Page 1288 of 1438